000 | 01692 a2200409 4500 | ||
---|---|---|---|
005 | 20250516234723.0 | ||
264 | 0 | _c20160815 | |
008 | 201608s 0 0 eng d | ||
022 | _a1527-7755 | ||
024 | 7 |
_a10.1200/JCO.2013.50.1320 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aHarding, Damian J | |
245 | 0 | 0 |
_aSuccessful Use of Dasatinib After Liver Transplantation for Imatinib-Induced Fulminant Liver Failure in Chronic Myeloid Leukemia. _h[electronic resource] |
260 |
_bJournal of clinical oncology : official journal of the American Society of Clinical Oncology _cApr 2016 |
||
300 |
_ae97-8 p. _bdigital |
||
500 | _aPublication Type: Case Reports; Journal Article | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 |
_aAntineoplastic Agents _xadministration & dosage |
650 | 0 | 4 |
_aDasatinib _xadministration & dosage |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aFusion Proteins, bcr-abl _xantagonists & inhibitors |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aImatinib Mesylate _xadministration & dosage |
650 | 0 | 4 |
_aLeukemia, Myelogenous, Chronic, BCR-ABL Positive _xdrug therapy |
650 | 0 | 4 |
_aLiver Failure, Acute _xchemically induced |
650 | 0 | 4 | _aLiver Transplantation |
650 | 0 | 4 |
_aProtein Kinase Inhibitors _xadministration & dosage |
650 | 0 | 4 | _aTreatment Outcome |
700 | 1 | _aMacQuillan, Gerry | |
700 | 1 | _aHowman, Rebecca | |
700 | 1 | _ade Boer, Bastian | |
700 | 1 | _aAdams, Leon | |
700 | 1 | _aMitchell, Andrew | |
700 | 1 | _aJeffrey, Gary | |
773 | 0 |
_tJournal of clinical oncology : official journal of the American Society of Clinical Oncology _gvol. 34 _gno. 11 _gp. e97-8 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1200/JCO.2013.50.1320 _zAvailable from publisher's website |
999 |
_c24233920 _d24233920 |